Effect of early cryoprecipitate transfusion versus standard care in women who develop severe postpartum haemorrhage (ACROBAT) in the UK: a protocol for a pilot cluster randomised trial
Authors:
- Laura GreenLGLaura Green
- Jahnavi DaruJDJahnavi Daru
- Julie DoddsJDJulie Dodds
- Francisco Jose Gonzalez CarrerasFCFrancisco Jose Gonzalez Carreras
- Doris LanzDLDoris Lanz
- Javier ZamoraJZJavier Zamora
- Maria del Carmen Pardo LlorenteMLMaria del Carmen Pardo Llorente
- Teresa Pérez PérezTPTeresa Pérez Pérez
- Lorna SweeneyLSLorna Sweeney
- Shakila ThangaratinamSTShakila Thangaratinam
- Khalid Saeed KhanKKKhalid Saeed Khan
Open Access
Abstract
Introduction The incidence of severe postpartum haemorrhage (PPH) that requires blood transfusion is on the increase. Fibrinogen levels have been shown to drop early and significantly during PPH, which is associated with worse outcomes. Early fibrinogen replacement could potentially improve outcomes. No studies have investigated the clinical impact of early cryoprecipitate transfusion in PPH. Prior to performing a full-scale trial, a pilot study is needed to determine feasibility of the intervention and recruitment. Methods ACROBAT is a cluster-randomised pilot study with a qualitative evaluation. Four large London maternity units are randomised to either the intervention or control group. The intervention group will adapt their major obstetric haemorrhage procedures to administer cryoprecipitate early for primary PPH. The control group will retain their standard of care. We include women at >24 weeks gestation who are actively bleeding within 24 hours of delivery and for whom transfusion of red blood cells (RBCs) has been started. We exclude women who decline blood transfusions in advance or have inherited Factor XIII or fibrinogen deficiency. Due to the emergency nature of the intervention, informed consent for administering the intervention is waived. The primary objective is to assess the feasibility of administering cryoprecipitate within 90 min of RBC request, as compared with standard treatment where cryoprecipitate is given later or not at all. Secondary objectives include the feasibility of recruitment and data collection, reasons for and barriers to consent, preliminary maternal clinical outcomes, identification of the optimal infrastructure pathways for study delivery, and acceptability of the intervention and outcomes. Ethics and dissemination The trial has approvals from the London—Brighton & Sussex Research Ethics Committee (ref. 18/LO/2062), the Confidentiality Advisory Group (ref. 18/CAG/0199) and Health Research Authority (IRAS number 237959). Data analysis and publication of manuscripts will start in Q3 2020. Trial registration number ISRCTN12146519.Keywords
Funding Information
- Barts Charity (MGU0371)
This publication has 16 references indexed in Scilit:
- A practical guideline for the haematological management of major haemorrhageBritish Journal of Haematology, 2015
- Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe TraumaJAMA, 2015
- Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trialBritish Journal of Anaesthesia, 2012
- Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage studyIntensive Care Medicine, 2011
- Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trialThe Lancet, 2010
- The Epidemiology of Postpartum Hemorrhage in a Large, Nationwide Sample of DeliveriesAnesthesia & Analgesia, 2010
- Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative GroupBMC Pregnancy and Childbirth, 2009
- Strategies to manage major obstetric haemorrhageCurrent Opinion in Anaesthesiology, 2008
- The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhageJournal of Thrombosis and Haemostasis, 2007
- WHO analysis of causes of maternal death: a systematic reviewThe Lancet, 2006